Renaissance Technologies’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-52,315
Closed -$1.2M 3859
2020
Q4
$1.2M Buy
52,315
+14,115
+37% +$269K ﹤0.01% 2414
2020
Q3
$623K Sell
38,200
-29,300
-43% -$531K ﹤0.01% 2744
2020
Q2
$914K Sell
67,500
-5,600
-8% -$65.2K ﹤0.01% 2581
2020
Q1
$866K Buy
73,100
+53,900
+281% +$1.2M ﹤0.01% 2495
2019
Q4
$478K Buy
+19,200
New +$389K ﹤0.01% 2922
2019
Q3
Sell
-80,200
Closed -$1.82M 3820
2019
Q2
$1.82M Buy
80,200
+36,300
+83% +$979K ﹤0.01% 2375
2019
Q1
$1.41M Buy
+43,900
New +$1.36M ﹤0.01% 2504
2018
Q4
Sell
-95,158
Closed -$2.74M 3710
2018
Q3
$2.74M Sell
95,158
-363,149
-79% -$10.9M ﹤0.01% 2123
2018
Q2
$17.2M Buy
458,307
+10,707
+2% +$420K 0.02% 1019
2018
Q1
$17.6M Buy
447,600
+130,000
+41% +$4.75M 0.02% 1007
2017
Q4
$10.3M Buy
317,600
+68,803
+28% +$2.06M 0.01% 1369
2017
Q3
$7.75M Buy
248,797
+47,797
+24% +$1.41M 0.01% 1479
2017
Q2
$5.62M Buy
+201,000
New +$4.55M 0.01% 1632
2016
Q4
Sell
-51,300
Closed -$813K 3548
2016
Q3
$813K Buy
+51,300
New +$773K ﹤0.01% 2655
2015
Q3
Sell
-80,300
Closed -$2.3M 3440
2015
Q2
$2.3M Sell
80,300
-20,800
-21% -$545K 0.01% 1968
2015
Q1
$2.61M Buy
+101,100
New +$2.31M 0.01% 1769

Other funds holding XENT

Renaissance Technologies's XENT Position: Q1 2021 in Review

Renaissance Technologies sold out of Intersect ENT, Inc (XENT) in Q1 2021, closing a stake of 52,315 shares — an estimated $1.2M sold.

Renaissance Technologies first reported a position in XENT in Q1 2015 and held it in 16 quarters. The position peaked at $17.6M in Q1 2018. 108 funds tracked by Wall St. Rank hold XENT as of Q1 2021.

  • Renaissance Technologies reported no remaining Intersect ENT, Inc position as of Q1 2021 after selling out during the quarter.
  • Renaissance Technologies sold 52,315 Intersect ENT, Inc shares in Q1 2021, an estimated $1.2M.
  • Renaissance Technologies first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 16 quarters.
  • Renaissance Technologies's Intersect ENT, Inc position peaked at $17.6M in Q1 2018.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.